| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 10,750 | $30 | $365.5K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 54,400 | $1 | $217.6K |
| J0897 | Injection, denosumab, 1 mg | 10,260 | $20 | $184.7K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 14,990 | $10 | $149.9K |
| J9312 | Injection, rituximab, 10 mg | 1,400 | $60 | $88.3K |
| J3262 | Injection, tocilizumab, 1 mg | 17,150 | $10 | $85.8K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 5,460 | $10 | $43.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 460 | $90 | $43K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 200 | $60 | $12.4K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 250 | $50 | $12.3K |